Reduction of immunoglobulin G secretion in vitro following long term lymphoblastoid interferon (Wellferon) treatment in multiple sclerosis patients.

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Clinical and Experimental Immunology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 2957131PMCID PMC1542565
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Progressive multiple sclerosis: abnormal immune functions in vitro and aberrant correlation with enumeration of lymphocyte subpopulations.

  1986cited by this paper
• Increased IgG secretion by unstimulated mononuclear cells in active multiple sclerosis and functional assessment of the T8 subset.

  1985cited by this paper
• Subsets of T lymphocytes in relation to T lymphocyte function in multiple sclerosis.

  1985cited by this paper
• T cell subsets in multiple sclerosis. A longitudinal study of exacerbating-remitting cases.

  1985cited by this paper
• Peripheral blood lymphocyte sub-populations and multiple sclerosis.

  1984cited by this paper
• Leukocyte surface antigens in patients with multiple sclerosis.

  1984cited by this paper
• Cerebrospinal fluid rhinorrhea caused by bromocriptine therapy of prolactinoma

  1984cited by this paper
• Low T8 antigen density on lymphocytes in active multiple sclerosis

  1984cited by this paper
• Multiple sclerosis

  1984cited by this paper
• Analysis of T regulator cell surface markers and functional properties in multiple sclerosis.

  1984cited by this paper
• T-cell subsets in multiple sclerosis: a comparative study between cell surface antigens and function.

  1984cited by this paper
• Altered blood T-cell subsets in patients with multiple sclerosis.

  1984cited by this paper
• alpha-Interferon increases immunoglobulin production in cultured human mononuclear leukocytes.

  1983cited by this paper
• Suppressor T‐lymphocytes in multiple sclerosis: Analysis of patients with acute relapsing and chronic progressive disease

  1983cited by this paper
• Bacteria-derived human leukocyte interferons alter in vitro humoral and cellular immune responses.

  1983cited by this paper
• Immunoregulatory T‐cells and lymphocytotoxic antibodies in active multiple sclerosis: Weekly analysis over a six‐month period

  1983cited by this paper
• Modulation of polyclonal B cell differentiation by human leucocyte alpha interferon.

  1982cited by this paper
• Abnormal regulation of IgG production in multiple sclerosis

  1982cited by this paper
• Stimulation of natural killer cell activity and inhibition of proliferation of various leukemic cells by purified human leukocyte interferon subtypes.

  1982cited by this paper
• Interferon-mediated inhibition of human polyclonal immunoglobulin synthesis.

  1982cited by this paper
• Influence of azathioprine (Imuran) on in vitro immune function in multiple sclerosis

  1982cited by this paper
• Interferon acts directly on human B lymphocytes to modulate immunoglobulin synthesis.

  1981cited by this paper
• Augmentation of natural and antibody-dependent cell-mediated cytotoxicity by pure human leukocyte interferon

  1981cited by this paper
• Effect of interferon alpha on pokeweed mitogen-induced differentiation of human peripheral blood b lymphocytes.

  1981cited by this paper
• Modulation of the human in vitro antibody response by human leukocyte interferon preparations.

  1981cited by this paper
• Loss of suppressor T cells in active multiple sclerosis. Analysis with monoclonal antibodies.

  1980cited by this paper
• Deficit of suppressor T cells in active multiple sclerosis.

  1980cited by this paper
• Absence of virus-induced lymphocyte suppression and interferon production in multiple sclerosis.

  1979cited by this paper
• Altered regulation of mitogen responsiveness by suppressor cells in multiple sclerosis.

  1979cited by this paper
• Suppressor cell function in multiple sclerosis.

  1978cited by this paper
• Mitogen responsiveness and suppressor cell function in multiple sclerosis

  1978cited by this paper
• Immunosuppressive effects of lymphocyte (type II) and leucocyte (type I) interferon on primary antibody responses in vivo and in vitro.

  1977cited by this paper
• Suppressor cell activity after concanavalin A treatment of lymphocytes from normal donors

  1976cited by this paper
• Single step separation of human T and B cells using AET treated srbc rosettes.

  1976cited by this paper
• Mechanism of the suppressive effect of interferon on antibody synthesis in vivo.

  1975cited by this paper
• Effect of Human Leukocyte Interferon on the Response of Lymphocytes to Mitogenic Stimuli In Vitro

  1974cited by this paper
• Suppression of Mouse Antibody Producing Spleen Cells by Various Interferon Preparations

  1973cited by this paper
• On the evaluation of disability in multiple sclerosis

  1961cited by this paper

• GM-CSF-induced autoimmune gastritis in interferon alpha receptor deficient mice.

  2008cites this paper
• Myelin Basic Protein-primed T Cells Induce Nitric Oxide Synthase in Microglial Cells

  2002cites this paper
• Interferon-beta inhibits Th1 responses at the dendritic cell level. Relevance to multiple sclerosis.

  1999cites this paper
• Microglial production of TNF-alpha is induced by activated T lymphocytes. Involvement of VLA-4 and inhibition by interferonbeta-1b.

  1997cites this paper
• Microglial Production of TNF- a Is Induced by Activated T Lymphocytes

  1997cites this paper
• Current and Future Therapies for Myasthenia Gravis

  1997cites this paper
• In vitro and in vivo inhibition of mitogen‐driven T‐cell activation by recombinant interferon beta

  1993cites this paper
• Interferons in multiple sclerosis. A review of the evidence.

  1992cites this paper
• Interferons in Multiple Sclerosis

  1992cites this paper
• Systemic lymphoblastoid interferon therapy in chronic progressive multiple sclerosis. II. Immunologic evaluation

  1991cites this paper
• Systemic lymphoblastoid interferon therapy in chronic progressive multiple Sclerosis. I. Clinical and MRI evaluation

  1990cites this paper
• Subakute sklerosierende Panenzephalitis: Therapieversuche mit Interferon

  1989cites this paper
• Regulation of in vitro PWM-induced IgG secretion in humans.

  1989cites this paper
• Chronic progressive multiple sclerosis: changes in phenotype and function of T helper subsets.

  1989cites this paper
• Alpha‐interferon inhibits the expression of heavy chain mu messenger RNA in Daudi cells.

  1988cites this paper